ОГЛЯД СУЧАСНИХ ПІДХОДІВ ДО РОЗРОБКИ НАНОЛІКІВ
Abstract
The article deals with nanopharmacy, a new medical discipline that combines chemistry, physics and engineering to develop nanoscale systems used in diagnosis and therapy. The use of nanoparticles for the development of new nanodrugs requires a deep understanding not only of the properties of nanomaterials, but also of the pathophysiology of diseases. Nanopharmacy help solve complex problems associated with improving the effectiveness of existing therapeutic agents and the use of nanomaterials in the manufacture of nanodrugs.
References
Boisseau P., Loubaton B. Nanoscience and nanotechnologies: hopes and concerns Nanomedicine, nanotechnology in medicine. C. R. Physique. 2011: 620-636
EC, Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. ‘A European strategy for Key Enabling Technologies - A bridge to growth and jobs’. Retrieved from http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2012:0341:FIN:EN:PDF (2012).
Fattal E., Tsapis N. Nanomedicine technology: current achievements and new trends. Clin Transl Imaging (2014) 2:77–87. DOI 10.1007/s40336-014-0053-3
Jeevanandam J., Chan Y.S., Danquah M.K. Nano-formulations of drugs: Recent developments, impact and challenges. Biochimie. 2016 Sep-Oct;128-129:99-112. doi: 10.1016/j.biochi.2016.07.008.
Hadjidemetriou M., Al-Ahmady Z., Mazza M., Kostarelos K. The Emergence of Nanopharmacy: From Biology to Nanotechnology and Drug Molecules to Nanodrugs (In book: Pharmaceutical Nanotechnology: Innovation and Production). 2016, pp.43-62. DOI: 10.1002/9783527800681.ch3
Moritz M., Geszke-Moritz M. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers. Adv Clin Exp Med 2015, 24, 5, 749–758. DOI: 10.17219/acem/31802
Електронний ресурс: http://www.gfmer.ch/Medical_journals/Nanomedicine.htm.
Views:
235
Downloads:
272
Copyright (c) 2020 The authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
